// App-Quantinova.ai

2550 : SORAVE: A phase I trial to evaluate safety and efficacy of combination therapy with everolimus and sorafenib.

Researchers

Presenter

  • Christian Mattonet

Principal Investigators

  • Lucia Nogova

  • Matthias Scheffler

  • Roland Schnell

  • Max Schlaak

  • Kerstin Rhiem

  • Reinhard Buettner

  • Carsten Kobe

  • Uwe Fuhr

  • Ahmed Abbas Suleiman

  • Yingying Tian

  • Fritz Soergel

  • Karin Toepelt

Medical Centers

  • University of Cologne, Cologne, DE, Germany

  • Department 1 for Internal Medicine, Center for Integrated Oncology Koln-Bonn, University Hospital Cologne, Cologne, Germany

  • Institute of Pathology, University Hospital of Cologne, Cologne, Germany

  • Lung Cancer Group Cologne, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany

  • Institute of Pathology, University Hospital of Cologne, Cologne, Germany

  • Department of Dermatology, University Hospital, Cologne, GermanyInstitute for Biomedical and Pharmaceutical Research, Nuernberg-Heroldsberg, GermanyLung Cancer Group Cologne, Center for Integrated Oncology, University Hospital Cologne, Koeln, Germany

  • Institute for Pathology, University Hospital of Cologne, Center for Integrated Oncology, Cologne, Germany

  • Pioh, private practice for hematology and oncology, Frechen/Cologne, Germany, Cologne, Germany

  • Lung Cancer Group Cologne, Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital Cologne, Cologne, Germany

  • Lung Cancer Group Cologne, Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital Cologne, Cologne, Germany

  • Department of Dermatology, University Hospital, Cologne, Germany

  • Center of Familial Breast and Ovarian Cancer, Department of Gynecology and Obstetrics, University Hospital Cologne, Cologne, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Everolimus

  • Sorafenib

Outcome

  • N/A

Study Design

  • fixed dose

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved